Cargando…

Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development

BACKGROUND/AIMS: Gastric mucosal atrophy and intestinal metaplasia due to Helicobacter pylori infection are the main precursor lesions of gastric cancer. The aim of this study was to evaluate the long-term effects of H. pylori eradication on the progression of precancerous lesions to metachronous ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Han, Seung Jun, Kim, Sang Gyun, Lim, Joo Hyun, Choi, Ji Min, Oh, Sooyeon, Park, Jae Yong, Kim, Jung, Kim, Joo Sung, Jung, Hyun Chae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Editorial Office of Gut and Liver 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832337/
https://www.ncbi.nlm.nih.gov/pubmed/29069890
http://dx.doi.org/10.5009/gnl17073
_version_ 1783303308296847360
author Han, Seung Jun
Kim, Sang Gyun
Lim, Joo Hyun
Choi, Ji Min
Oh, Sooyeon
Park, Jae Yong
Kim, Jung
Kim, Joo Sung
Jung, Hyun Chae
author_facet Han, Seung Jun
Kim, Sang Gyun
Lim, Joo Hyun
Choi, Ji Min
Oh, Sooyeon
Park, Jae Yong
Kim, Jung
Kim, Joo Sung
Jung, Hyun Chae
author_sort Han, Seung Jun
collection PubMed
description BACKGROUND/AIMS: Gastric mucosal atrophy and intestinal metaplasia due to Helicobacter pylori infection are the main precursor lesions of gastric cancer. The aim of this study was to evaluate the long-term effects of H. pylori eradication on the progression of precancerous lesions to metachronous cancer after endoscopic resection of early gastric cancer (EGC). METHODS: Patients who underwent endoscopic resection of EGC were retrospectively reviewed. Changes in precancerous lesions and development of metachronous cancer were compared according to H. pylori eradication and final infection status. RESULTS: In total, 565 patients were followed for over 5 years after endoscopic resection of EGC. The grade of atrophy on corpus was significantly lower in the H. pylori-eradicated group than in the persistent group during follow-up (p=0.029). In patients <70 years of age, the cumulative incidence rate of metachronous cancer was significantly lower in the H. pylori-eradicated group than in the persistent group (p=0.018). Age was an independent risk factor for metachronous cancer development. CONCLUSIONS: H. pylori eradication might prevent the development of metachronous cancer in patients <70 years of age by delaying the progression of precancerous lesions after endoscopic resection of EGC.
format Online
Article
Text
id pubmed-5832337
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Editorial Office of Gut and Liver
record_format MEDLINE/PubMed
spelling pubmed-58323372018-03-16 Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development Han, Seung Jun Kim, Sang Gyun Lim, Joo Hyun Choi, Ji Min Oh, Sooyeon Park, Jae Yong Kim, Jung Kim, Joo Sung Jung, Hyun Chae Gut Liver Original Article BACKGROUND/AIMS: Gastric mucosal atrophy and intestinal metaplasia due to Helicobacter pylori infection are the main precursor lesions of gastric cancer. The aim of this study was to evaluate the long-term effects of H. pylori eradication on the progression of precancerous lesions to metachronous cancer after endoscopic resection of early gastric cancer (EGC). METHODS: Patients who underwent endoscopic resection of EGC were retrospectively reviewed. Changes in precancerous lesions and development of metachronous cancer were compared according to H. pylori eradication and final infection status. RESULTS: In total, 565 patients were followed for over 5 years after endoscopic resection of EGC. The grade of atrophy on corpus was significantly lower in the H. pylori-eradicated group than in the persistent group during follow-up (p=0.029). In patients <70 years of age, the cumulative incidence rate of metachronous cancer was significantly lower in the H. pylori-eradicated group than in the persistent group (p=0.018). Age was an independent risk factor for metachronous cancer development. CONCLUSIONS: H. pylori eradication might prevent the development of metachronous cancer in patients <70 years of age by delaying the progression of precancerous lesions after endoscopic resection of EGC. Editorial Office of Gut and Liver 2018-03 2017-10-27 /pmc/articles/PMC5832337/ /pubmed/29069890 http://dx.doi.org/10.5009/gnl17073 Text en Copyright © 2018 by The Korean Society of Gastroenterology, the Korean Society of Gastrointestinal Endoscopy, the Korean Society of Neurogastroenterology and Motility, Korean College of Helicobacter and Upper Gastrointestinal Research, Korean Association the Study of Intestinal Diseases, the Korean Association for the Study of the Liver, Korean Pancreatobiliary Association, and Korean Society of Gastrointestinal Cancer. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Han, Seung Jun
Kim, Sang Gyun
Lim, Joo Hyun
Choi, Ji Min
Oh, Sooyeon
Park, Jae Yong
Kim, Jung
Kim, Joo Sung
Jung, Hyun Chae
Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title_full Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title_fullStr Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title_full_unstemmed Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title_short Long-Term Effects of Helicobacter pylori Eradication on Metachronous Gastric Cancer Development
title_sort long-term effects of helicobacter pylori eradication on metachronous gastric cancer development
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5832337/
https://www.ncbi.nlm.nih.gov/pubmed/29069890
http://dx.doi.org/10.5009/gnl17073
work_keys_str_mv AT hanseungjun longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT kimsanggyun longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT limjoohyun longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT choijimin longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT ohsooyeon longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT parkjaeyong longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT kimjung longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT kimjoosung longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment
AT junghyunchae longtermeffectsofhelicobacterpylorieradicationonmetachronousgastriccancerdevelopment